U 3773 U 3773 (Ogen 1.25 1.5 mg)
Generic Name: estropipate
Pill imprint U 3773 U 3773 has been identified as Ogen 1.25 1.5 mg.
Ogen 1.25 is used in the treatment of postmenopausal symptoms; osteoporosis; oophorectomy; primary ovarian failure; hypoestrogenism (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Ogen 1.25 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- estropipate
- Imprint:
- U 3773 U 3773
- Strength:
- 1.5 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00009-3773
More about Ogen 1.25 (estropipate)
Consumer resources
- Other brands: Ortho-Est
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
